您的购物车当前为空
LTV-1 has the potential for autoimmunity treatment. LTV-1 is a potent lymphoid tyrosine phosphatase (LYP) inhibitor in T cells with an IC50 of 508 nM.

LTV-1 has the potential for autoimmunity treatment. LTV-1 is a potent lymphoid tyrosine phosphatase (LYP) inhibitor in T cells with an IC50 of 508 nM.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 1,370 | 5日内发货 | |
| 25 mg | ¥ 6,910 | 6-8周 | |
| 50 mg | ¥ 9,170 | 6-8周 | |
| 100 mg | ¥ 14,200 | 6-8周 |
LTV-1 相关产品
| 产品描述 | LTV-1 has the potential for autoimmunity treatment. LTV-1 is a potent lymphoid tyrosine phosphatase (LYP) inhibitor in T cells with an IC50 of 508 nM. |
| 靶点活性 | LYP (T cells):508 nM |
| 体外活性 | LTV-1 is not cytotoxic in HeLa cells, Jurkat TAg T cells and peripheral blood mononuclear cells (PBMC)[1].even at the highest concentration tested (40 μM). |
| 分子量 | 472.51 |
| 分子式 | C26H20N2O5S |
| CAS No. | 347379-29-7 |
| 密度 | 1.45 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (105.82 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容